Sila Iii (triamcinolone acetonide/gauze bandage/silicone, adhesive)
Topical Corticosteroids Topical Kit
Last reviewed · Source: First Databank (FDB) drug data
Overview
Triamcinolone acetonide is a synthetic fluorinated corticosteroid.
Triamcinolone shares the actions of the other topical corticosteroids and is used for the relief of the inflammatory manifestations of corticosteroid-responsive dermatoses. The drug is also used as a paste for adjunctive treatment to provide temporary relief of symptoms associated with oral inflammatory or ulcerative lesions resulting from trauma.
Generic name: triamcinolone acetonide/gauze bandage/silicone, adhesive
Pronunciation: (trye-am-SIN-oh-lone)
Drug class: Topical Corticosteroids
Therapeutic class: Dermatological
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Sila Iii
Indications
No indications are available for this drug.
Dosing
Dermatologic preparations of triamcinolone acetonide are applied sparingly in thin films and are rubbed gently into the affected area 2-4 times daily. The 0.5% cream and 0.5% ointment should be used only in the treatment of dermatoses which are refractory to treatment with lower concentrations. The 0.1 and 0.5% creams are applied 2-3 times daily according to severity of the condition. When the aerosol is applied, an area about the size of the patient's hand is sprayed for about 2 seconds from a distance of about 7.5-15 cm 3 or 4 times daily. Occlusive dressings may be used for severe or resistant dermatoses.
For use in the mouth, a small amount (about 0.6 cm) of the 0.1% paste is pressed to the lesion without rubbing until a thin film develops; a larger amount may be required to cover some lesions. The paste is applied at bedtime and, if necessary, 2 or 3 times daily, preferably after meals. If substantial regeneration or repair of the oral tissues does not occur after 7 days of treatment, further investigation of the etiology of the oral lesions should be undertaken.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
- Adrenocortical insufficiency
- Telangiectasia
Adverse reactions
There is no enhanced messaging for this drug.
Less Frequent
- Folliculitis
- Purpura
- Skin and skin structure infection
- Skin atrophy
Rare or Very Rare
- Adrenocortical insufficiency
- Bullous dermatitis
- Cataracts
- Central serous chorioretinopathy
- Glaucoma
- Growth failure
- Hypothalamic-pituitary insufficiency
- Intracranial hypertension
- Ocular hypertension
- Skin hypopigmentation
- Skin striae
- Skin ulcer
- Urticaria
More Frequent
- Erythema
- Stinging of skin
Less Frequent
- Acute pain at drug application site
- Blurred vision
- Headache disorder
- Paresthesia
- Pruritus of skin
- Skin rash
- Telangiectasia
- Treatment site sequelae
Rare or Very Rare
- Acneiform eruption
- Alopecia
- Blistering skin
- Contact dermatitis
- Dry skin
- Dyschromia
- Glycosuria
- Hirsutism
- Hypercortisolism
- Hyperesthesia
- Hyperglycemia
- Miliaria
- Perioral dermatitis
- Skin irritation
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.